Aureos Capital

Aureos Capital

Sev Vettivetpillai and a team of former CDC Group professionals launched Aureos Capital in 2001 as a private equity manager focused exclusively on small and medium enterprises in emerging markets. The spinout included CDC's legacy $140 million portfolio of direct SME investments, creating one of the first dedicated multi-region SME platforms. The firm structured regional funds across Africa, South Asia, Southeast Asia, and Latin America, typically targeting minority and control investments with equity tickets under $10 million. The strategy split across two core activities: direct SME growth equity and a fund-of-funds program backing local emerging-market managers. Aureos Africa Fund I and Aureos Southeast Asia Fund anchored the direct arm, while Aureos Latin America Fund managed commitments from development finance institutions including CDC, FMO, and IFC. Portfolio exposure concentrated in healthcare, consumer goods, light manufacturing, and financial services — sectors where SME penetration offered entry multiples below developed-market private equity. Known portfolio companies included Mozambique-based pharmaceutical distributor Medis Farmaceutica and Kenyan insurance broker Pacific Insurance Brokers. Aureos Capital managed over $1.1 billion in aggregate commitments at its peak, operating from offices in London, Nairobi, Johannesburg, Kuala Lumpur, and San José. The firm's structure linked regional investment committees to a central London capital formation team. In 2012, Aureos shareholders agreed to sell the franchise to Abraaj Capital, the Dubai-based emerging-market private equity group then managing roughly $7.5 billion. The merger, which closed in mid-2012, folded Aureos's 140-plus staff and portfolio into Abraaj's existing platform, with Vettivetpillai joining Abraaj's senior leadership (per Financial Times, 2012). The Abraaj integration marked a structural endpoint for the standalone Aureos brand, converting a founder-led SME specialist into a division of a larger institutional manager. No public record indicates ongoing investment activity under the original Aureos Capital name post-2012. The legacy persists through residual portfolio entities and the careers of former investment professionals, many of whom subsequently launched or joined sub-Saharan Africa-focused funds including EXEO Capital and Adenia Partners.